$149.5 Million
Keros Therapeutics
Follow-On Offering
Active Bookrunner
$48.3 Million
Aptinyx Inc.
Follow-On Offering
Active Bookrunner
$203.9 Million
I-Mab Biopharma
Follow-On Offering
Active Bookrunner
$225.8 Million
Seres Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$216.8 Million
Adverum Biotechnologies, Inc.
Follow-On Offering
Active Bookrunner
$201.0 Million
Cytokinetics, Incorporated
Follow-On Offering
Active Bookrunner
$142.6 Million
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
$48.0 Million
TELA Bio, Inc.
Follow-On Offering
Active Bookrunner
$120.8 Million
Oyster Point Pharma, Inc.
Follow-On Offering
Active Bookrunner
$125.0 Million
Avadel Pharmaceuticals
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.